Anne L Angiolillo
Overview
Explore the profile of Anne L Angiolillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta S, Rau R, Kairalla J, Rabin K, Wang C, Angiolillo A, et al.
N Engl J Med
. 2024 Dec;
392(9):875-891.
PMID: 39651791
Background: B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among...
2.
Rheingold S, Bhojwani D, Ji L, Xu X, Devidas M, Kairalla J, et al.
Leukemia
. 2024 Sep;
38(11):2382-2394.
PMID: 39261601
Limited prognostic factors have been associated with overall survival (OS) post-relapse in childhood Acute Lymphoblastic Leukemia (ALL). Patients enrolled on 12 Children's Oncology Group frontline ALL trials (1996-2014) were analyzed...
3.
Rabin K, Devidas M, Chen Z, Ji L, Kairalla J, Hitzler J, et al.
J Clin Oncol
. 2023 Oct;
42(2):218-227.
PMID: 37890117
Purpose: Patients with Down syndrome (DS) and B-ALL experience increased rates of relapse, toxicity, and death. We report results for patients with DS B-ALL enrolled on Children's Oncology Group trials...
4.
Rodwin R, DelRocco N, Hibbitts E, Devidas M, Whitley M, Mohrmann C, et al.
Pediatr Blood Cancer
. 2023 Aug;
70(11):e30634.
PMID: 37592363
Chemotherapy-induced peripheral neuropathy (CIPN), a common condition in children with acute lymphoblastic leukemia, can be challenging to diagnose. Using data from Children's Oncology Group AALL0932 physical function study, we sought...
5.
Schore R, Angiolillo A, Kairalla J, Devidas M, Rabin K, Zweidler-McKay P, et al.
Leukemia
. 2023 May;
37(6):1406.
PMID: 37157018
No abstract available.
6.
Schore R, Angiolillo A, Kairalla J, Devidas M, Rabin K, Zweidler-McKay P, et al.
Leukemia
. 2023 Mar;
37(6):1375-1378.
PMID: 36966262
No abstract available.
7.
Gupta S, Dai Y, Chen Z, Winestone L, Teachey D, Bona K, et al.
Lancet Haematol
. 2023 Feb;
10(2):e129-e141.
PMID: 36725118
Background: Previous studies have identified racial and ethnic disparities in childhood acute lymphocytic leukaemia survival. We aimed to establish whether disparities persist in contemporaneous cohorts and, if present, are attributable...
8.
Brady S, Roberts K, Gu Z, Shi L, Pounds S, Pei D, et al.
Nat Genet
. 2022 Sep;
54(9):1376-1389.
PMID: 36050548
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low...
9.
Rodwin R, Kairalla J, Hibbitts E, Devidas M, Whitley M, Mohrmann C, et al.
J Natl Cancer Inst
. 2022 May;
114(8):1167-1175.
PMID: 35552709
Background: Children with B-acute lymphoblastic leukemia (B-ALL) are at risk for chemotherapy-induced peripheral neuropathy (CIPN). Children's Oncology Group AALL0932 randomized reduction in vincristine and dexamethasone (every 4 weeks vs 12...
10.
Angiolillo A, Schore R, Kairalla J, Devidas M, Rabin K, Zweidler-McKay P, et al.
J Clin Oncol
. 2021 Jan;
39(13):1437-1447.
PMID: 33411585
Purpose: AALL0932 evaluated two randomized maintenance interventions to optimize disease-free survival (DFS) while reducing the burden of therapy in children with newly diagnosed NCI standard-risk (SR) B-acute lymphoblastic leukemia (B-ALL)....